Bär & Karrer Ltd. | View firm profile
Bär & Karrer Advises Sanofi on Exchange Transaction with Boehringer
Ingelheim
Sanofi and Boehringer Ingelheim confirmed closing (in most markets) on 1 January 2017 of a $25 billion transaction involving the exchange of Sanofi’s
animal health business and Boehringer Ingelheim’s consumer healthcare business.
Bär
& Karrer acted as Swiss legal advisor to Sanofi. The team included Ralph
Malacrida, Micha Schilling (both M&A), Mani Reinert (Competition), Markus
Wang, and Raffael Nusser (both IP). Weil, Gotshal & Manges LLP acted as
global lead counsel to Sanofi.